drugset / Trial / NCT00351143

A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control

NCT00351143

Phase 4 Completed 274 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will investigate whether study subjects with previously uncontrolled asthma treated with SERETIDE Diskus 50/250 CCI18781+GR33343 mcg twice a day can attain a level of Total Control of their condition and whether adherence to treatment can be enhanced by teaching the subjects. Two groups of equal size with identical medical treatment will be compared with each other, the test group receiving three training modules during study visits and the control group regular study visits only.

Timeline

Start
2005-07-26
Primary completion
2007-06-13
Completion
2007-06-13

Drugs

EvaluationDrugModalityDoseRoute
Background Fluticasone propionate Other / unclassified 250 ug
Background Salmeterol Other / unclassified 50 ug

Indications